There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have
not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in
humans. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed
veterinarian. Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan.
Brief Summary Indications: For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated
lameness of the carpal and hock joints in horses.
See Product Package Insert at www.adequan.com for Full Prescribing Information
Adequan
®
is a registered trademark of Luitpold Pharmaceuticals, Inc.
© Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2015. Photo by Anne M. Eberhardt,
Copyright Blood-Horse Publications used with permission. Triple Crown is a registered trademark of
Triple Crown Productions LLC. AHD132 Rev. 6/2015
Now Available!
The Winning Formula
for Champions
The only FDA-approved PSGAG on
the market for equine intramuscular
use proven to:
• STOP the destructive disease cycle
• REVERSE degenerative joint disease
• IMPROVE joint function
For more information on equine joint
health and treatment with Adequan
®
i.m.
(polysulfated glycosaminoglycan),
please visit www.adequan.com.
American Pharoah, the 12th winner of the elusive Triple Crown
®
!
Owned by the Zayat Racing Stable, trained by Bob Baffert and ridden by
Victor Espinoza, American Pharoah won the 141st Kentucky Derby, the
140th Preakness Stakes and the 147th Belmont Stakes.